CoChat

Therapeutic aspects of growth hormone and insulin‐like growth factor‐I treatment on visceral fat and insulin sensitivity in adults

Yuen, K. C. J., Dunger, D. B. · 2007 · Diabetes, Obesity and Metabolism
Cited by 78

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Growth hormone (GH) is generally considered to exert anti‐insulin actions, whereas insulin‐like growth factor I (IGF‐I) has insulin‐like properties. Paradoxically, GH deficient adults and those with acromegaly are both predisposed to insulin resistance, but one cannot extrapolate from these pathological conditions to determine the normal metabolic roles of GH and IGF‐I on glucose homeostasis. High doses of GH treatment have major effects on lipolysis, which plays a crucial role in promoting its anti‐insulin effects, whereas IGF‐I acts as an insulin sensitizer that does not exert any direct effect on lipolysis or lipogenesis. Under physiological conditions, the insulin‐sensitizing effect of IGF‐I is only evident after feeding when the bioavailability of circulating IGF‐I is increased. In contrast, many studies in GH deficient adults have consistently shown that GH replacement improves the body composition profile although these studies differ considerably in terms of age, the presence or absence of multiple pituitary hormone deficiency, and whether GH deficiency was childhood or adult‐onset. However, the improvement in body composition does not necessarily translate into improvements in insulin sensitivity presumably due to the anti‐insulin effects of high doses of GH therapy. More recently, we have found that a very low dose GH therapy (0.1 mg/day) improved insulin sensitivity without affecting body composition in GH‐deficient adults and in subjects with metabolic syndrome, and we postulate that these effects are mediated by its ability to increase free ‘bioavailable’ IGF‐I without the induction of lipolysis. These results raise the possibility that this low GH dose may play a role in preventing the decline of β‐cell function and the development of type 2 diabetes in these “high risk” subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2006.00591.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 78

Metadata

Authors
Yuen, K. C. J., & Dunger, D. B.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2006-04-20
Volume
9
Issue
1
Pages
11-22
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2159169885
Cited by
78
References
10
FWCI
3.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.